Brazilian federal police officers stand guard near the venue hosting the UN Climate Change Conference (COP30), a day after ...
Brazil said it would extend negotiations at the COP30 summit to give nations time to bridge divides over thorny differences on climate goals and the finances required to achieve them.
In reaching a wider audience, the 2025 event at Del Mar took two steps forward, and one step back. Has exclusivity of the ...
We know what landmarks look like today, but structures like the Statue of Liberty and the Sydney Opera House looked a little ...
Founded in 2007 with a vision to revolutionize how the world manages carbon dioxide emissions, Svante has grown into a cornerstone of the global carbon management industry. In 2025, that vision took a ...
From Queen Elizabeth and Princess Margaret to George and Charlotte and Louis, we're rounding up the cutest royal family ...
Perhaps no other actor has a fleeting relationship with public life than Daniel Day-Lewis, so it's no surprise that when it comes to his personal life, not much is known. The famously elusive actor ...
Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON) (OTCQX: BMOOF), is pleased to report the voting results from the Company's Annual General and Special Meeting of Shareholders (the ...
Toronto Life on MSN

The Influentials 2025

In a world first, Lipsman and his team in Sunnybrook’s Hurvitz Brain Sciences Program non-invasively breached the blood-brain barrier using a focused ultrasound procedure guided by MRI. It allowed ...
MMA and BJJ champion Rafael Lovato Jr says at age 42 he is at the best stage of his evolution yet, as he sat down with The Sporting News to talk about his ONE 173 matchup with ADCC champion Giancarlo ...
The Beast In Me' new mystery thriller on Netflix starring Claire Danes and Matthew Rhys featuring the official trailer, plot, ...
R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advan ...